PhD candidate attends prestigious neuropharmacology school
HONOURED: Elias Chipofya
Tuesday, 10 December 2024
Elias Chipofya, a PhD candidate at the Applied Microbial and Health Biotechnology Institute (AMHBI), was awarded a prestigious travel scholarship and recently attended the 2nd School on Neuropharmacology Research and Drug Development in Harare, Zimbabwe.
The programme was organised and sponsored by the International Brain Research Organization (IBRO) through the African Regional Committee (ARC), in collaboration with the University of Zimbabwe's Department of Pharmacy and Pharmaceutical Sciences.
The school provided participants with a comprehensive understanding of fundamental pharmacological principles and practices required for researching potential neuroactive compounds. This knowledge and skillset will empower them to transform traditional natural compounds into potent therapeutic agents or preventive strategies, ultimately contributing to the development of innovative treatments and preventions for neurological disorders.
Elias, who is supervised by Dr Taskeen Docrat and Prof Jeanine L. Marnewick, expressed deep gratitude for receiving the travel scholarship, acknowledging it as a testament to his dedication and hard work in neuroscience research. “This transformative experience allowed me to learn cutting-edge techniques in neuropharmacology and network with leading experts in the field. I am excited to apply this newfound knowledge to my research on Rooibos and its potential neuroprotective effects.”
Docrat, his main supervisor, added: “The scholarship will open doors to new opportunities and collaborations, propelling his research to new heights”.
Elias' research focuses on the protective effects of Rooibos herbal tea, a topic of growing interest. With limited knowledge on how Rooibos affects the brain, his research aims to uncover the neuroprotective mechanisms of its antioxidant compounds to prevent Alzheimer's disease and related disorders. "By understanding these mechanisms, we may develop novel preventive strategies to combat neurodegenerative diseases and improve the quality of life for millions worldwide," said Docrat.
Written by CPUT News
Email: news@cput.ac.za
News categories
- Accommodation 8
- Advancement 7
- Alumni 79
- Awards 14
- Campus Life 24
- Community Engagement 172
- Disability Unit 11
- Applied Sciences 90
- Business & Management Sciences 82
- Education 97
- Engineering & the Built Environment 124
- Health & Wellness Sciences 76
- Informatics & Design 59
- Fundani CHED 21
- Funding 19
- GBV 15
- Graduation 46
- HIV/Aids Unit 51
- Library 19
- News 3545
- RTIP 306
- Residences 7
- Short Courses 1
- Staff 688
- SIP 33
- Students 1400
- Student Counselling 5
- Student Health 47
- Sport, Arts & Culture 100
- SRC 5
- Student Affairs 13
- University Leadership 8
- Varsity Shield 8
- Vice-Chancellor 11
- Work Integrated Learning 12
- THENSA 12